LD
TMO icon

Lipe & Dalton’s Thermo Fisher Scientific TMO Stock Holding History

Lipe & Dalton’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Sell
8,533
-207
-2% -$99.4K 1.99% 18
2026
Q1 		$4.3M Sell
8,740
-360
-4% -$195K 2.25% 12
2025
Q4 		$5.27M Sell
9,100
-154
-2% -$87.1K 2.6% 10
2025
Q3 		$4.49M Sell
9,254
-150
-2% -$69.8K 2.22% 12
2025
Q2 		$3.81M Buy
+9,404
New +$3.93M 2.06% 16

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Lipe & Dalton's TMO Position: Q2 2026 in Review

Lipe & Dalton reduced its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, selling an estimated $99.4K and leaving 8,533 shares worth $4.28M. The position accounts for 1.99% of the portfolio, ranked #18.

Lipe & Dalton first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.27M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lipe & Dalton held 8,533 shares of Thermo Fisher Scientific worth $4.28M as of Q2 2026.
  • Lipe & Dalton sold 207 Thermo Fisher Scientific shares in Q2 2026, an estimated $99.4K.
  • Thermo Fisher Scientific made up 1.99% of Lipe & Dalton's portfolio in Q2 2026, its #18 holding.
  • Lipe & Dalton first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Lipe & Dalton's Thermo Fisher Scientific position peaked at $5.27M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.